Showing results (761-770 of 12,112) with videos related to
Sort By:
Pageof 1,212
Neuropharmacology|April 1, 1988
Negative feedback regulation of the content of proenkephalin mRNA in chromaffin cell culturesJ R Naranjo, B C Wise, B Mellstrom, et al.Neuropharmacology|April 1, 1988
Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintainance of body weight in ratsP E Mann, G W Pasternak, E F Hahn, et al.Neuropharmacology|April 1, 1988
On the epileptogenic effects of kainic acid and dihydrokainic acid in the dentate gyrus of the ratS P Butcher, I Jacobson, A HambergerNeuropharmacology|June 1, 1988
Dopamine in the basal ganglia and benzodiazepine-induced sedationN Brose, R D O'Neill, M G Boutelle, et al.Neuropharmacology|June 1, 1988
Uptake in brain and neurophysiological activity of two lipid esters of gamma-aminobutyric acidG W Hesse, J N Jacob, V E ShashouaNeuropharmacology|June 1, 1988
Clip-induced analgesia and immobility in the mouse: pharmacological characterizationA Fleischmann, G UrcaNeuropharmacology|July 1, 1988
Effects of gamma-hydroxybutyrate and gamma-butyrolactone derivates on spontaneous generalized non-convulsive seizures in the ratA Depaulis, J J Bourguignon, C Marescaux, et al.Neuropharmacology|June 22, 2021
CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactionsAna Covelo, Abel Eraso-Pichot, Ignacio Fernández-Moncada, et al.Neuropharmacology|June 27, 2021
Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat modelJunying Lan, Yuling Hu, Xiaoqing Wang, et al.Neuropharmacology|June 21, 2021
MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's diseaseKemeng Pan, Song Chen, Yue Wang, et al.Pageof 1,212